|
Name |
Pyrenosetin D
|
Molecular Formula | C25H35NO6 | |
IUPAC Name* |
(1S,2R,3S,5S,6R,9S,11R,12S,15S,17R)-5-hydroxy-6-(hydroxymethyl)-7,11,15,19-tetramethyl-3-(2-oxopropyl)-4-oxa-7-azapentacyclo[9.8.0.02,9.05,9.012,17]nonadec-18-ene-8,10-dione
|
|
SMILES |
C[C@H]1CC[C@H]2[C@H](C1)C=C([C@H]3[C@@]2(C(=O)[C@@]45[C@@H]3[C@@H](O[C@@]4([C@H](N(C5=O)C)CO)O)CC(=O)C)C)C
|
|
InChI |
InChI=1S/C25H35NO6/c1-12-6-7-16-15(8-12)9-13(2)19-20-17(10-14(3)28)32-25(31)18(11-27)26(5)22(30)24(20,25)21(29)23(16,19)4/h9,12,15-20,27,31H,6-8,10-11H2,1-5H3/t12-,15+,16-,17-,18+,19+,20+,23+,24+,25+/m0/s1
|
|
InChIKey |
VGSLZTMSEGAQSR-AOIDCAQBSA-N
|
|
Synonyms |
Pyrenosetin D
|
|
CAS | NA | |
PubChem CID | 156581964 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 445.5 | ALogp: | 1.3 |
HBD: | 2 | HBA: | 6 |
Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 104.0 | Aromatic Rings: | 5 |
Heavy Atoms: | 32 | QED Weighted: | 0.51 |
Caco-2 Permeability: | -5.221 | MDCK Permeability: | 0.00003020 |
Pgp-inhibitor: | 0.988 | Pgp-substrate: | 0.996 |
Human Intestinal Absorption (HIA): | 0.775 | 20% Bioavailability (F20%): | 0.01 |
30% Bioavailability (F30%): | 0.971 |
Blood-Brain-Barrier Penetration (BBB): | 0.69 | Plasma Protein Binding (PPB): | 51.47% |
Volume Distribution (VD): | 0.446 | Fu: | 44.02% |
CYP1A2-inhibitor: | 0.01 | CYP1A2-substrate: | 0.356 |
CYP2C19-inhibitor: | 0.028 | CYP2C19-substrate: | 0.877 |
CYP2C9-inhibitor: | 0.016 | CYP2C9-substrate: | 0.016 |
CYP2D6-inhibitor: | 0.002 | CYP2D6-substrate: | 0.099 |
CYP3A4-inhibitor: | 0.352 | CYP3A4-substrate: | 0.797 |
Clearance (CL): | 11.367 | Half-life (T1/2): | 0.524 |
hERG Blockers: | 0.027 | Human Hepatotoxicity (H-HT): | 0.182 |
Drug-inuced Liver Injury (DILI): | 0.083 | AMES Toxicity: | 0.04 |
Rat Oral Acute Toxicity: | 0.362 | Maximum Recommended Daily Dose: | 0.108 |
Skin Sensitization: | 0.639 | Carcinogencity: | 0.818 |
Eye Corrosion: | 0.039 | Eye Irritation: | 0.016 |
Respiratory Toxicity: | 0.806 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005775 | 0.536 | D0E9KA | 0.292 | ||||
ENC004322 | 0.536 | D0I5DS | 0.282 | ||||
ENC005774 | 0.509 | D04SFH | 0.273 | ||||
ENC004320 | 0.509 | D06AEO | 0.266 | ||||
ENC004321 | 0.509 | D08PIQ | 0.262 | ||||
ENC005181 | 0.426 | D03IKT | 0.258 | ||||
ENC005182 | 0.426 | D0F1EX | 0.258 | ||||
ENC003818 | 0.413 | D0IX6I | 0.256 | ||||
ENC002818 | 0.403 | D0IL7L | 0.256 | ||||
ENC003817 | 0.402 | D0Y7IU | 0.255 |